Status unknownPhase 4Relapsing and progressiveNCT03424733

What it found

Result in a paper, not read yet

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Peginterferon beta-1a

    Interferon alpha/beta receptor agonist

  • Prednisone

    Glucocorticoid receptor agonist

  • Acetaminophen

    Anandamide amidohydrolase inhibitor|Cyclooxygenase inhibitor|Vanilloid receptor opener

What it measured

Main measures

  • Flu-like symptoms

    12 to 16 weeks

    FatigueSafety

Other measures (1)

  • Injection site reactions

    12 to 16 weeks

    PainSafety

Who could take part

Relapsing and progressive · 18 and over

Inclusion Criteria: * diagnosed any form of MS (relapsing remitting, primary progressive, secondary progressive), any EDSS (expanded stability status scale) score Exclusion Criteria: * prior allergic reaction to interferon products, congestive heart failure, elevated liver enzymes

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Some of the most common side effects of the multiple sclerosis drug Plegridy (pegylated interferon beta-1a) include flu-like symptoms and injection site reactions. Physicians often advise patients to take Tylenol or aspirin prior to injection, but in this study the investigators evaluated whether using a low dose of oral steroid in combination with Tylenol reduced flu-like symptoms and injection site reactions.

Papers

Loading reviews and guidelines…

Related trials

History

    1. Started

      Sept 2017

    2. Main results due

      May 2020

    3. Finished

      May 2020

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error